Results 21 to 30 of about 150,310 (246)

Role of CD4+T, CD8+T Cells, and CD4+T/CD8+T Cell Ratio in Gastric Cancer and Its Clinical Significance

Applied Bionics and Biomechanics, 2022
Objective. To study the expression and clinical importance of CD4+T, CD8+T cells, and CD4+T/CD8+T cell percentage in gastric cancer (GC) patients. Methods.
Jingqi Han, Linglin Zhao, Jianying Wu, Yinzhuo Diao, Qijing Guo, Jie Yang, Yushuang Luo   +6 more
doaj   +1 more source

The CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis [PDF]

European Journal of Clinical Microbiology & Infectious Diseases, 2016
There is great heterogeneity of immunity among patients with cryptococcosis, and severe immunodeficiency can lead to negative clinical outcomes. Underlying disease is a poor surrogate for immune status and inferior in predicting an individual's prognosis.
Ming-Ming Tan, Ting Wu, Yuan Ding, Yi Shi, Qian He, H. Wei, Xin Su, Pei Li, Di Xia   +8 more
openaire   +3 more sources

CD4+ T-Lymphocyte Count/CD8+ T-Lymphocyte Count Ratio: Surrogate for HIV Infection in Infants? [PDF]

Journal of Tropical Pediatrics, 2012
Early diagnosis and treatment is necessary to prevent HIV-infected infants progressing to AIDS. Antibody testing is not confirmatory before the age of 18 months and PCR not widely available in resource-poor settings. We studied the accuracy of CD4(+) T-lymphocyte count, CD4% and CD4/CD8 ratio as surrogate markers of infant HIV infection.Two hundred and
Navaneethapandian, P. G. D., Karunaianantham, R., Subramanyan, S., Chinnayan, P., Chandrasekaran, P., Swaminathan, S.   +5 more
openaire   +4 more sources

Disease progression and its influencing factors among HIV/AIDS patients on antiretroviral therapy in Yili, Xinjiang Uygur Autonomous Region: a multi-state Markov model analysis on follow-up data

Zhongguo gonggong weisheng, 2023
ObjectiveTo analyze disease progression and its influencing factors in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) patients on antiretroviral therapy (ART) with Markov modeling.MethodsWe recruited a total of 2 000 HIV/AIDS
Arezu·Rouziniyazi, Meng SHAN, Xiaomin HU, Xiaoyan HE, Jing CHEN, Mingjian NI   +5 more
doaj   +1 more source

Physics of a rapid CD4 lymphocyte count with colloidal gold [PDF]

Cytometry Part A, 2011
AbstractThe inherent surface charges and small diameters that confer colloidal stability to gold particle conjugates (immunogold) are detrimental to rapid cell surface labeling and distinct cluster definition in flow cytometric light scatter assays.
A. Restell, Frederic I. Preffer, P. Hansen, Olivier Magnin, D. Sylvia, David Dombkowski, D. Barry   +6 more
openaire   +3 more sources

Emerging technologies for point-of-care CD4 T-lymphocyte counting [PDF]

Trends in Biotechnology, 2012
A CD4 T-lymphocyte count determines eligibility for antiretroviral therapy (ART) in patients recently diagnosed with HIV and also monitors the efficacy of ART treatment thereafter. ART slows the progression of HIV to AIDS. In the developing world, CD4 tests are often performed in centralized laboratories, typically in urban areas.
Kenneth R. Hawkins, Mitra Singhal, Matthew S. Steele, David S. Boyle, Xuanhong Cheng   +4 more
openaire   +3 more sources

A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study [PDF]

, 2006
Objective: The objective of the trial was to evaluate in a pilot setting the safety and efficacy of interleukin-2 (IL-2) therapy when used without concomitant antiretroviral therapy as a treatment for HIV infection.
Abrams, Ann Sullivan, Carr, Carr, Carr, Christian Herzmann, Clive Loveday, Connelly, Crespo-Fierro, Davey, Davey, Davey, Dewar, Emery, Emery, Emery, George Janossy, H. Clifford Lane, Handan Wand, Jorge A Tavel, Kovacs, Kovacs, Lederman, Levy, Lisa Fosdick, Losso, Margaret A Johnson, Mark Nelson, Martin Fisher, Matthews, Mercolino, Mike Youle, Palella, Pillay, Pozniak, Richard T Davey, Ruxrungtham, Sean Emery, Sereti, Sereti, Smith, Stein, Urdea, Verbeke, Yeni   +44 more
core   +2 more sources

CD4 LYMPHOCYTE IN HIV / AIDS BEFORE AND AFTER ANTIRETROVIRAL THERAPY

Berkala Kedokteran, 2017
: Human Immunodefficiency Virus (HIV) is a virus that decreases the human immunity system, therefore the infected people become susceptible to any kind of infections.
Rangsang Bagus Prabowo, Dewi Indah Noviana Pertiwi, FX. Hendriyono   +2 more
doaj   +1 more source

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. [PDF]

, 2007
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients.
Akileswaran, Babiker, Badri, Braitstein, Calmy, Carr, Coetzee, Cozzi-Lepri, Dragsted, Egger, Ferradini, French, Furber, Hirsch, Ivers, Kaufmann, Keiser, Laurent, Lawn, Le Moing, Mahajan, Matthews, Mocroft, Pean, Ratnam, Severe, Shetty, Smit, Smith, Sungkanuparph, van Leth   +30 more
core   +2 more sources

Absolute Lymphocyte Count as a Surrogate Marker of CD4 Count in Monitoring HIV Infected Individuals: A Prospective Study [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: CD4 cell count has been proposed to be substituted by Absolute lymphocyte count in monitoring HIV infected individuals as methods of CD4 cell count and plasma viral estimation require expensive, specialized equipments and highly trained
PREETI BALKISANJI AGRAWAL, SHARDA RAJU RANE, MEENAL VITTHAL JADHAV   +2 more
doaj   +1 more source